Saltar al contenido
Merck
  • Coordinated histone H3 methylation and acetylation regulate physiologic and pathologic fas ligand gene expression in human CD4+ T cells.

Coordinated histone H3 methylation and acetylation regulate physiologic and pathologic fas ligand gene expression in human CD4+ T cells.

Journal of immunology (Baltimore, Md. : 1950) (2014-06-06)
Smita S Ghare, Swati Joshi-Barve, Akshata Moghe, Madhuvanti Patil, David F Barker, Leila Gobejishvili, Guy N Brock, Matthew Cave, Craig J McClain, Shirish S Barve
RESUMEN

Activation-induced Fas ligand (FasL) mRNA expression in CD4+ T cells is mainly controlled at transcriptional initiation. To elucidate the epigenetic mechanisms regulating physiologic and pathologic FasL transcription, TCR stimulation-responsive promoter histone modifications in normal and alcohol-exposed primary human CD4+ T cells were examined. TCR stimulation of normal and alcohol-exposed cells led to discernible changes in promoter histone H3 lysine trimethylation, as documented by an increase in the levels of transcriptionally permissive histone 3 lysine 4 trimethylation and a concomitant decrease in the repressive histone 3 lysine 9 trimethylation. Moreover, acetylation of histone 3 lysine 9 (H3K9), a critical feature of the active promoter state that is opposed by histone 3 lysine 9 trimethylation, was significantly increased and was essentially mediated by the p300-histone acetyltransferase. Notably, the degree of these coordinated histone modifications and subsequent recruitment of transcription factors and RNA polymerase II were significantly enhanced in alcohol-exposed CD4+ T cells and were commensurate with the pathologic increase in the levels of FasL mRNA. The clinical relevance of these findings is further supported by CD4+ T cells obtained from individuals with a history of heavy alcohol consumption, which demonstrate significantly greater p300-dependent H3K9 acetylation and FasL expression. Overall, these data show that, in human CD4+ T cells, TCR stimulation induces a distinct promoter histone profile involving a coordinated cross-talk between histone 3 lysine 4 and H3K9 methylation and acetylation that dictates the transcriptional activation of FasL under physiologic, as well as pathologic, conditions of alcohol exposure.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Alcohol etílico puro, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Alcohol etílico puro, 200 proof, meets USP testing specifications
Sigma-Aldrich
Alcohol etílico puro, 190 proof, for molecular biology
Sigma-Aldrich
Etanol, BioUltra, for molecular biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 4.8% isopropanol, A15 IPA1, ≥99.8% (based on denaturant-free substance)
Supelco
Etanol, standard for GC
Sigma-Aldrich
Etanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Supelco
Etanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Etanol, for residue analysis
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 2% 2-butanone, A15 MEK1, ≥99.8% (based on denaturant-free substance)
USP
Etanol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Etanol, purum, fine spirit, denaturated with 2% 2-butanone, F25 MEK1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Etanol, tested according to Ph. Eur.
Sigma-Aldrich
Etanol, purum, secunda spirit, denaturated with 2% 2-butanone, S15, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Fas Ligand from mouse, >95% (SDS-PAGE), recombinant, expressed in mouse NSO cells, lyophilized powder
Sigma-Aldrich
Fas Ligand human, >95% (SDS-PAGE), recombinant, expressed in CHO cells, lyophilized powder
Sigma-Aldrich
MISSION® esiRNA, targeting human NOTCH1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Ep300
Sigma-Aldrich
MISSION® esiRNA, targeting human EP300
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Notch1